12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | December 22, 2022 01:32pm

Gainers

• IsoPlexis (NASDAQ:ISO) stock moved upwards by 131.1% to $1.59 during Thursday's regular session. Trading volume for IsoPlexis's stock is 33.5 million as of 12:30 EST. This is 80056.9% of its average full-day volume over the last 100 days. The company's market cap stands at $63.1 million.
• Scopus BioPharma (NASDAQ:SCPS) shares moved upwards by 76.61% to $0.11. As of 12:30 EST, this security is trading at a volume of 293.1K shares, making up 30.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million.
• ORIC Pharmaceuticals (NASDAQ:ORIC) stock moved upwards by 55.56% to $4.67. The current volume of 25.5 million shares is 23562.9% of ORIC Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $184.7 million.
• Baudax Bio (NASDAQ:BXRX) stock rose 29.64% to $2.93. As of 12:30 EST, Baudax Bio's stock is trading at a volume of 608.4K, which is 102.9% of its average full-day volume over the last 100 days. The company's market cap stands at $1.6 million.
• Alvotech (NASDAQ:ALVO) shares rose 20.6% to $10.01. The current volume of 707.9K shares is 1579.8% of Alvotech's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $2.4 billion.
• Mereo BioPharma Group (NASDAQ:MREO) shares moved upwards by 20.06% to $0.68. As of 12:30 EST, Mereo BioPharma Group's stock is trading at a volume of 467.9K, which is 95.4% of its average full-day volume over the last 100 days. The company's market cap stands at $84.9 million.

Losers

• Lannett (NYSE:LCI) stock declined by 20.9% to $0.68 during Thursday's regular session. The current volume of 423.0K shares is 248.5% of Lannett's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $28.5 million.
• Celyad Oncology (NASDAQ:CYAD) stock decreased by 20.4% to $0.57. The market value of their outstanding shares is at $12.9 million.
• 180 Life Sciences (NASDAQ:ATNF) stock decreased by 20.38% to $1.68. As of 12:30 EST, this security is trading at a volume of 942.7K shares, making up 175.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.3 million.
• Immuron (NASDAQ:IMRN) shares decreased by 16.9% to $1.61. The market value of their outstanding shares is at $9.1 million.
• Ambrx Biopharma (NYSE:AMAM) shares decreased by 16.27% to $1.64. As of 12:30 EST, this security is trading at a volume of 471.9K shares, making up 14.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $63.3 million.
• Gossamer Bio (NASDAQ:GOSS) shares declined by 14.88% to $1.66. As of 12:30 EST, this security is trading at a volume of 2.6 million shares, making up 61.0% of its average full-day volume over the last 100 days. The company's market cap stands at $156.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALVO AMAM ATNF BXRX CYAD GOSS IMRN ISO LCI MREO ORIC SCPS